Vivani Medical VANI Income Statement (2014-2026)

NASDAQ VANI
$1.32 -0.04 (-2.94%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Vivani Medical Quarterly Income Statement

Periods 50 quarters
Latest Jun 2026

Vivani Medical reported net income of -$6.37M for the quarter ended Jun 2026. This income statement covers 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.00M1.60M
Cost of RevenueCost of Rev
Gross Profit
0.13M
Operating items
Research & DevelopmentR&D
2.87M2.98M2.68M3.20M3.86M4.46M3.96M3.86M4.44M4.74M3.73M3.51M4.20M4.30M4.22M4.76M4.52M4.63M4.39M4.46M
Selling, General & AdministrativeSG&A
0.62M0.57M1.23M0.88M1.58M3.36M2.65M3.14M2.70M1.51M2.50M2.17M2.11M2.16M2.34M2.70M2.21M2.18M2.43M2.42M
Restructuring CostsRestructuring
0.27M0.26M0.30M-0.01M0.21M0.33M0.29M0.28M0.37M0.58M
Other Operating ExpensesOther Opex
-0.01M-0.02M-0.02M6.87M0.51M0.28M0.48M0.36M0.19M0.19M0.33M0.27M0.01M0.26M0.32M0.20M-0.28M0.04M0.50M
Operating ExpensesOpex
3.48M3.55M3.91M4.09M5.44M7.79M6.60M7.00M7.14M6.22M6.23M5.68M6.31M6.46M6.56M7.46M6.72M6.81M6.82M6.87M
Operating IncomeOp. Inc
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
EBIT
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
Net income details
EBT
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Profit After TaxPAT
-3.49M-1.28M-3.92M-4.10M1.42M-7.26M-6.32M-6.53M-6.80M-6.03M-6.04M-5.36M-6.04M-6.09M-6.30M-7.14M-6.53M-6.65M-6.78M-6.37M
Income from Continuing OperationsIncome (Continuing)
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Consolidated Net IncomeConsol Net Inc.
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Income towards Parent CompanyParent Net Inc
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Net Income towards Common StockholdersNet Income
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Additional items
EPS (Basic)
-0.27-0.12-297.43-311.13-143.40-203.71-0.13-0.14-0.14-0.12-0.12-0.10-0.11-0.12-0.11-0.13-0.11-0.11-0.08-0.08
EPS (Diluted)
-103.11-38.20-106.15-110.82-141.49-202.46-171.56-0.14-0.14-0.12-0.12-0.10-0.11-0.12-0.11-0.13-0.11-0.11-0.08-0.08
Shares Outstanding
13.14M10.94M0.01M0.01M0.04M0.04M50.76M50.80M50.84M50.85M52.20M55.02M55.25M54.98M59.24M59.24M59.71M62.39M81.27M87.09M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.03M0.03M0.04M0.04M0.04M0.04M0.04M50.80M50.84M50.85M52.20M55.02M55.25M54.98M59.24M59.24M59.71M62.39M81.27M87.09M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
13.14M10.94M0.01M0.01M0.04M0.04M50.79M50.82M51.03M51.03M54.98M55.20M55.27M59.23M59.24M59.24M61.51M62.39M84.65M89.41M
EBITDA
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M